1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Bioabsorbable Scaffolds - Current and Future Players

Bioabsorbable Scaffolds - Current and Future Players

Summary

Coronary artery disease (CAD) and peripheral artery disease (PAD) are global public health and socioeconomic issues that affect millions of lives each year. Bioabsorbable scaffolds (BAS), which provide transient support to the vessel, are viable alternatives to permanent drug-eluting stents (DES) and bare metal stents (BMS) implants. In the report, BAS are defined as fully-bioabsorbable devices that are used in stenting procedures that completely disappear from the target vessel overtime. Stents such as BioMatrix Flex by Biosensors International and Synergy by Boston Scientific Corporation are not included in the report because they are metallic DES with bioabsorbable polymer coatings. Absorption of the bioabsorbable polymer coating still leaves behind a permanent BMS inside the vessel.

The report provides up-to-date information and in-depth analysis on the key players that shape the global bioabsorbable scaffolds market. The report includes an analysis of company profiles, industry trends, and corporate strategy. This report is built using data and information sourced from secondary sources, primary research interviews with leading cardiovascular experts, and in-house analysis conducted by GlobalData’s team of industry experts.

*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.

Highlights

Key Benefits

- “What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading physicians and other stakeholders from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Scope

- Investigation of current and future market competition for advanced wound dressings.
- Competitive Assessment including product profiles.
- Coverage of key market players, which includes company profiles, business descriptions, financial overviews, portfolio assessments, and SWOT analyses.
- Strategic Assessment of the market through market impact analysis, future market scenario, and company analysis.

Reasons to buy

- Gain a high level view of the trends shaping and driving the Bioabsorbable Scaffolds market.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Drive revenues, formulate effective sales and marketing strategies, and gain in-depth understanding of the competitive landscape.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.

Table Of Contents

Bioabsorbable Scaffolds - Current and Future Players
1 Table of Contents

2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Competitive Assessment
3.1 Overview
3.2 Absorb BVS - Abbott Vascular
3.2.1 Efficacy
3.3 Remedy - Kyoto Medical Planning
3.3.1 Efficacy
3.4 DESolve - Elixir Medical Corperation
3.4.1 Efficacy
3.5 Pure - Arterial Remodeling Technologies
3.5.1 Efficacy
4 Pipeline Products
4.1 Overview
4.2 Coronary Artery Disease - Pipeline Products
4.2.1 Overview
4.2.2 Polymer-Based Bioabsorbable Scaffolds
4.2.3 Metallic Bioabsorbable Scaffolds
4.2.4 Summary
4.3 Peripheral Artery Disease - Peripheral Bioabsorbable Scaffold Product Pipeline
4.3.1 Overview
4.3.2 Summary
5 Current and Future Players
5.1 Overview
5.2 Trends in Corporate Strategy
5.3 Company Profiles
5.3.1 Abbott Vascular
5.3.2 Kyoto Medical Planning Co., Ltd.
5.3.3 Arterial Remodeling Technologies
5.3.4 Elixir Medical Corporation
5.3.5 Cardionovum
5.3.6 Reva Medical
5.3.7 OrbusNeich Medical
5.3.8 Amaranth Medical
5.3.9 Biotronik
5.3.10 Lepu Medical Technology
5.3.11 HuaAn Biotechnology Co., Ltd.
5.3.12 Lifetech Scientific (Shenzhen) Co., LTD. (Lifetech Shenzhen)
5.3.13 Arterius
5.3.14 S3V Vascular Technologies
5.3.15 Tepha Inc.
5.3.16 Zorion Medical
5.3.17 Xenogenics Corporation
5.3.18 Meril Life Sciences
5.3.19 Boston Scientific Corporation
5.3.20 Icon Interventional Systems
6 Appendix
6.1 Bibliography
6.2 Abbreviations
6.3 Report Methodology
6.3.1 Overview
6.3.2 Coverage
6.3.3 Primary Research -Key Opinion Leader Interviews
6.3.4 Primary Research Interviews - Physician and Industry Participants
6.3.5 Physician Survey
6.3.6 Expert Panel Validation
6.3.7 Secondary Research
6.4 Forecasting Methodology
6.5 Physicians and Specialists Included in This Study
6.6 About the Authors
6.6.1 Analysts
6.6.2 James Coutcher, Global Head of Healthcare
6.7 About GlobalData
6.8 Contact Us
6.9 Disclaimer

1.1 List of Tables
Table 1: Marketed BAS Products
Table 2: Absorb BVS Product Profile
Table 3: Absorb BVS Clinical Trials
Table 4: Absorb BVS SWOT Analysis, 2015
Table 5: Remedy Product Profile
Table 6: Remedy SWOT Analysis, 2015
Table 7: DESolve Product Profile
Table 8: DESolve Clinical Trials
Table 9: DESolve SWOT Analysis, 2015
Table 10: Pure Product Profile
Table 11: Pure SWOT Analysis, 2015
Table 12: Coronary BAS Product Pipeline, 2015
Table 13: Igaki-Tamai Stent SWOT Analysis, 2015
Table 14: Fantom Scaffold SWOT Analysis, 2015
Table 15: ART18Z Scaffold SWOT Analysis, 2015
Table 16: Fortitude Scaffold SWOT Analysis, 2015
Table 17: ArterioSorb Scaffold SWOT Analysis, 2015
Table 18: Xinsorb Scaffold SWOT Analysis, 2015
Table 19: Ideal BioStent SWOT Analysis, 2015
Table 20: DREAMS Scaffold SWOT Analysis, 2015
Table 21: Peripheral BAS Product Pipeline, 2015
Table 22: Magic Explorer Scaffold SWOT Analysis, 2015
Table 23: ESPRIT BVS Stent SWOT Analysis, 2015
Table 24: Abbott Vascular Company Profile
Table 25: Marketed BAS Products by Abbott Vascular
Table 26: Pipeline BAS Products by Abbott Vascular
Table 27: Abbott Vascular SWOT Analysis, 2015
Table 28: Kyoto Medical Planning Company Profile
Table 29: Marketed BAS Products by Kyoto Medical Planning
Table 30: Pipeline BAS Products by Kyoto Medical Planning
Table 31: Kyoto Medical Planning SWOT Analysis, 2015
Table 32: ART Company Profile
Table 33: Marketed BAS Products by ART
Table 34: ART's BAS Pipeline Products
Table 35: ART SWOT Analysis, 2015
Table 36: Elixir Medical Corporation Company Profile
Table 37: Marketed BAS Products by Elixir Medical
Table 38: Elixir Medical Corporation SWOT Analysis, 2015
Table 39: Cardionovum Company Profile
Table 40: Cardionovum's BAS Pipeline Products
Table 41: Cardionovum SWOT Analysis, 2015
Table 42: REVA Medical's BAS Pipeline Products
Table 43: REVA Medical SWOT Analysis, 2015
Table 44: OrbusNeich Medical Company Profile
Table 45: OrbusNeich Medical's BAS Pipeline Products
Table 46: OrbusNeich Medical SWOT Analysis, 2015
Table 47: Amaranth Medical Company Profile
Table 48: Amaranth Medical's BAS Pipeline Products
Table 49: Amaranth Medical SWOT Analysis, 2014
Table 50: Biotronik Company Profile
Table 51: Biotronik's BAS Pipeline Products
Table 52: Biotronik SWOT Analysis, 2015
Table 53: Lepu Medical Technology Company Profile
Table 54: Lepu Medical Technology's BAS Pipeline Products
Table 55: Lepu Medical Technology SWOT Analysis, 2015
Table 56: HuaAn Biotechnology Co., Ltd. Company Profile
Table 57: HuaAn Biomedical Co., Ltd.'s BAS Pipeline Products
Table 58: HuaAn Biomedical Co., Ltd. SWOT Analysis, 2015
Table 59: Lifetech Scientific Co., LTD Company Profile
Table 60: Lifetech Scientific's BAS Pipeline Products
Table 61: Lifetech Scientific SWOT Analysis, 2015
Table 62: Arterius Company Profile
Table 63: Arterius BAS Pipeline Products
Table 64: Arterius SWOT Analysis, 2015
Table 65: S3V Vascular Technologies Company Profile
Table 66: S3V Vascular Technologies' BAS Pipeline Product
Table 67: S3V Vascular Technologies SWOT Analysis, 2015
Table 68: Tepha Inc. Company Profile
Table 69: Tepha Inc.'s BAS Pipeline Product
Table 70: Tepha Inc. SWOT Analysis, 2015
Table 71: Zorion Medical Company Profile
Table 72: Zorion Medical's BAS Pipeline Product
Table 73: Zorion Medical SWOT Analysis, 2015
Table 74: Xenogenics Corporation Company Profile
Table 75: Xenogenics Corporation's BAS Pipeline Product
Table 76: Xenogenics Corporation SWOT Analysis, 2015
Table 77: Meril Life Sciences Company Profile
Table 78: Meril Life Science's BAS Pipeline Product
Table 79: Meril Life Sciences SWOT Analysis, 2015
Table 80: Boston Scientific Corporation Company Profile
Table 81: Boston Scientific Corporation SWOT Analysis, 2015
Table 82: Icon Interventional Systems Company Profile
Table 83: Primary Research Interviews Completed
Table 84: Physicians Surveyed, By Country



Companies Mentioned
Abbott Vascular
Kyoto Medical Planning Co., Ltd.
Arterial Remodeling Technologies
Elixir Medical Corporation
Cardionovum
Reva Medical
OrbusNeich Medical
Amaranth Medical
Biotronik
Lepu Medical Technology
HuaAn Biotechnology Co., Ltd.
Lifetech Scientific

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Global Markets for Diabetes Therapeutics and Diagnostics

Global Markets for Diabetes Therapeutics and Diagnostics

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Analyze the market for drugs used in the treatment of diabetes, it's technology and the industry as a whole - Identify important trends and provide sales forecasts by product categories ...

Bovine Respiratory Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Bovine Respiratory Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Global Bovine Respiratory Disease Treatment Market: Overview Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.